Day: November 21, 2022

PARIS, Nov. 21, 2022 (GLOBE NEWSWIRE) — Boralex Inc. (“Boralex” or the “Company”) (TSX: BLX) is pleased to announce the commissioning of the Bougainville Repowering wind farm in the French department of Somme (Hauts-de-France region). The repowering of the wind farm, which was first commissioned in 2005 and has been operated by Boralex since 2018, has increased production by more than 50% through the installation of 6 next-generation wind turbines, for an upgraded installed capacity of 18 MW.Project statistics:Commissioning date: November 15, 2022 Wind turbines: 6 Vestas V126 Total capacity before repowering: 12 MW Total capacity after repowering: 18 MW Equivalence in household energy needs met after repowering: 16,000+ householdsInitially commissioned in 2005, the Bougainville wind farm is the industry’s first wind energy...

Dave Rush Appointed Interim Chief Executive OfficerDave Flitman to Step Down to Pursue New OpportunityReaffirming Full Year 2022 Guidance DALLAS, Nov. 21, 2022 (GLOBE NEWSWIRE) — Builders FirstSource, Inc. (NYSE: BLDR) (“Builders FirstSource” or the “Company”) today announced that its Chief Executive Officer, Dave Flitman, has stepped down as President, CEO and member of the Board of Directors (the “Board”) to accept another opportunity outside of the industry. The Board has appointed Dave Rush, Executive Vice President, to serve as interim Chief Executive Officer, effective immediately, until a permanent successor is named. The Board has also formed a special committee, led by Chairman Paul Levy, to oversee the search for a new CEO. Rush, 60, has spent 23 years with Builders FirstSource. In his current role as Executive...

Treatment with UNI-494 improved contrast vision in animal models of geographic atrophy (GA) GA is an advanced form of Age-related Macular Degeneration (AMD) and there are currently no FDA-approved drugs to slow the progression of AMD LOS ALTOS, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with unmet medical needs, today announced key findings of UNI-494 efficacy from a preclinical study in animal models of Geographic Atrophy (GA). UNI-494 is a mitochondrial potassium channel (mitochondrial KATP) activator in development for treating diseases affected by mitochondrial dysfunction, such as kidney, liver, and ocular diseases. Mitochondrial dysfunction is implicated in Age-related Macular Degeneration (AMD) progression....

SAN MATEO, Calif. and SINGAPORE, Nov. 21, 2022 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced Dr Carl Firth, CEO, is scheduled to participate in a fireside chat at the Piper Sandler Healthcare Conference on Thursday, December 1, 2022, at 8:30am ET. The conference will be held from November 29 to December 1, 2022, in-person at the Lotte New York Palace Hotel, New York, NY. A replay of the fireside chat will be made available on the Investor Relations section of ASLAN’s website and can be accessed directly at this link. Management will be available for one-on-one meetings with investors throughout the conference. Please contact your representative at Piper Sandler to schedule...

CALGARY, Alberta, Nov. 21, 2022 (GLOBE NEWSWIRE) — Helium Evolution Incorporated (TSXV:HEVI) (“HEVI” or the “Company“), a Canadian-based helium exploration and production company focused on finding, developing and commercializing assets in southern Saskatchewan, today provides an update on the first of two wells that will be drilled by year end 2022 (the “First Test Well”), NAH Grasslands 13-30-2-8W3, on farmout lands within Block 1 at Mankota in Saskatchewan. The First Test Well was drilled and fully funded by HEVI’s farmout partner, North American Helium (“NAH”), pursuant to a previously announced farmout arrangement (see press releases dated October 21, 2022, and June 28, 2022). After reaching total depth over the weekend, NAH has informed HEVI that the open hole portion of the First Test Well will be...

CALGARY, Alberta, Nov. 21, 2022 (GLOBE NEWSWIRE) — NXT Energy Solutions Inc. (“NXT” or the “Company”) (TSX: SFD; OTCQB: NSFDF) would like to remind its shareholders of the upcoming deadlines and essential details of its previously announced rights offering (the “Rights Offering”) made to the holders of common shares of the Company (“Common Shares”) of record at the close of business on November 7, 2022 (the “Record Date”). The rights (“Rights”) will expire at 4:30 p.m. (Calgary time) on November 30, 2022 (the “Expiry Time”), after which time unexercised Rights will be void and of no value. Accelerated Deadlines It is important to note that intermediaries may have different cut off times prior to the Expiry Time, which could be as early as November 22, 2022. As such, the Company recommends...

Supply Path Optimization Agreement Brings Buyers Efficiency Across CTV and Omnichannel Formats NEW YORK and REDWOOD CITY, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) — Horizon Media, the largest media agency in the U.S., today announced a supply path optimization (SPO) partnership with PubMatic (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future. Buying premium media inventory has become increasingly complex across formats and devices, with new challenges in targeting fragmented audiences. Partnering with PubMatic will add value to Horizon Media clients’ direct, transparent, and simplified access to high-value audiences and premium inventory, including CTV, at unprecedented scale. “Horizon’s relationship with PubMatic gives our clients access to audiences at scale across channels,...

NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 21, 2022 (GLOBE NEWSWIRE) — Meraki Acquisition One, Inc. (TSXV:MRKI.P) (the “Company”) is pleased to announce that on November 21, 2022, it entered into a definitive agreement (the “Agreement”) with Vaultex Pte. Ltd. (“Vaultex”), Vaultex’s operating subsidiary and Vaultex’s security holders setting out the binding terms and conditions for an arm’s length reverse takeover acquisition to constitute the Company’s qualifying transaction (the “Transaction”) under the policies of the TSX Venture Exchange (the “Exchange”). The Transaction and its proposed terms and conditions were first announced by the Company in a news release dated April 8, 2022 and updated on May 6, 2022 and on June 20, 2022. Transaction Pursuant...